{"id":80391,"date":"2023-10-05T18:39:59","date_gmt":"2023-10-05T13:09:59","guid":{"rendered":"http:\/\/finservwealth.com\/valiant-laboratories-ipo-listing-tomorrow-stock-may-debut-at-15-18-premium\/"},"modified":"2023-10-05T18:39:59","modified_gmt":"2023-10-05T13:09:59","slug":"valiant-laboratories-ipo-listing-tomorrow-stock-may-debut-at-15-18-premium","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/valiant-laboratories-ipo-listing-tomorrow-stock-may-debut-at-15-18-premium\/","title":{"rendered":"Valiant Laboratories IPO: Listing tomorrow, stock may debut at 15-18% premium"},"content":{"rendered":"<p> Valiant Laboratories IPO was subscribed 29.76 times with investors buying 22.68 crore shares against the offer size of 76.23 lakh<\/p><div id=\"finse-3931844166\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/valiant-laboratories-ipo-listing-tomorrow-stock-may-debut-at-15-18-premium_17261281.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Valiant Laboratories IPO was subscribed 29.76 times with investors buying 22.68 crore shares against the offer size of 76.23 lakh Valiant Laboratories IPO was subscribed 29.76 times with investors buying 22.68 crore shares against the offer size of 76.23 lakh\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/valiant-laboratories-ipo-listing-tomorrow-stock-may-debut-at-15-18-premium_17261281.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> Valiant Laboratories IPO was subscribed 29.76 times with investors buying 22.68 crore shares against the offer size of 76.23 lakh<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/valiant-laboratories-ipo-listing-tomorrow-stock-may-debut-at-15-18-premium_17261281.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Valiant Laboratories IPO was subscribed 29.76 times with investors buying 22.68 crore shares against the offer size of 76.23 lakh Valiant Laboratories IPO was subscribed 29.76 times with investors buying 22.68 crore shares against the offer size of 76.23 lakh\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/valiant-laboratories-ipo-listing-tomorrow-stock-may-debut-at-15-18-premium_17261281.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> Valiant Laboratories IPO was subscribed 29.76 times with investors buying 22.68 crore shares against the offer size of 76.23 lakh<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-80391","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2017\/200x200\/G\/GettyImages-520687032_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/80391","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=80391"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/80391\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=80391"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=80391"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=80391"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}